Call Options

18 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$57.33 - $68.61 $2.58 Million - $3.09 Million
45,000 New
45,000 $2.97 Million
Q1 2022

May 17, 2022

SELL
$66.02 - $79.71 $4.28 Million - $5.17 Million
-64,900 Reduced 38.68%
102,900 $8.17 Million
Q4 2021

Feb 15, 2022

BUY
$63.34 - $74.11 $7.86 Million - $9.2 Million
124,100 Added 283.98%
167,800 $12.3 Million
Q3 2021

Nov 16, 2021

BUY
$68.67 - $84.02 $281,547 - $344,482
4,100 Added 10.35%
43,700 $3.01 Million
Q2 2021

Aug 16, 2021

SELL
$79.87 - $87.53 $223,636 - $245,084
-2,800 Reduced 6.6%
39,600 $3.33 Million
Q1 2021

May 18, 2021

SELL
$76.02 - $100.5 $342,090 - $452,250
-4,500 Reduced 9.59%
42,400 $3.45 Million
Q4 2020

Feb 17, 2021

BUY
$80.74 - $97.7 $40,370 - $48,850
500 Added 1.08%
46,900 $4.08 Million
Q3 2020

Nov 17, 2020

SELL
$85.07 - $109.69 $7.03 Million - $9.06 Million
-82,600 Reduced 64.03%
46,400 $4.16 Million
Q2 2020

Aug 17, 2020

BUY
$74.18 - $108.93 $8.92 Million - $13.1 Million
120,300 Added 1382.76%
129,000 $13.4 Million
Q1 2020

May 15, 2020

SELL
$63.18 - $85.97 $543,348 - $739,342
-8,600 Reduced 49.71%
8,700 $637,000
Q4 2019

Feb 14, 2020

SELL
$73.04 - $95.72 $1.28 Million - $1.68 Million
-17,500 Reduced 50.29%
17,300 $1.51 Million
Q3 2019

Nov 14, 2019

BUY
$72.82 - $86.52 $1.54 Million - $1.83 Million
21,200 Added 155.88%
34,800 $2.58 Million
Q2 2019

Aug 15, 2019

BUY
$73.52 - $88.7 $654,328 - $789,430
8,900 Added 189.36%
13,600 $1.16 Million
Q1 2019

May 16, 2019

SELL
$63.56 - $88.17 $108,052 - $149,889
-1,700 Reduced 26.56%
4,700 $404,000
Q3 2018

Nov 14, 2018

SELL
$61.75 - $74.23 $419,900 - $504,764
-6,800 Reduced 51.52%
6,400 $442,000
Q2 2018

Aug 15, 2018

SELL
$60.85 - $83.98 $3.47 Million - $4.8 Million
-57,100 Reduced 81.22%
13,200 $884,000
Q1 2018

May 15, 2018

BUY
$83.06 - $100.98 $4.34 Million - $5.28 Million
52,300 Added 290.56%
70,300 $5.86 Million
Q3 2017

Nov 14, 2017

BUY
$109.15 - $138.27 $1.96 Million - $2.49 Million
18,000
18,000 $2.1 Million

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $15.5B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.